LMO7 anticorps (AA 616-644)

N° du produit ABIN1881503

L’anticorps Lapin Polyclonal anti-LMO7 a été validé pour WB. Il convient pour détecter LMO7 dans des échantillons de Humain.

Aperçu rapide pour LMO7 anticorps (AA 616-644) (ABIN1881503)

Antigène: LMO7 (LIM Domain 7 (LMO7))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LMO7 est non-conjugé

Application: Western Blotting (WB)

Clone: RB41024

Détail du produit anti-LMO7 anticorps

Épitope: AA 616-644

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This LMO7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 616-644 amino acids from the Central region of human LMO7.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Détails sur LMO7

Antigène: LMO7 (LIM Domain 7 (LMO7))

Autre désignation: LMO7

Sujet: LMO7 contains a calponin homology (CH) domain, a PDZ domain, and a LIM domain. An F-box (FBX) domain is present in alternative splice variants. Members of the LIM protein family carry the LIM domain, a unique cysteine-rich zinc-binding domain. Members of the FBX protein family are involved in protein-protein interactions. LMO7 may be involved in protein-protein interactions. Multiple alternative splice variants have been described but their full-length sequences have not been determined.

Poids moléculaire: 192696

NCBI Accession: NP_005349, NP_056667

UniProt: Q8WWI1